Cardiovascular problems for two types of Diabetes medicines
Description
A comparison of cardiovascular problems for Rosiglitazone and Pioglitazone.

Usage
avandia
Format
A data frame with 227571 observations on the following 2 variables.

treatment
a factor with levels Pioglitazone and Rosiglitazone

cardiovascular_problems
a factor with levels no and yes

Source
D.J. Graham et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. In: JAMA 304.4 (2010), p. 411. issn: 0098-7484.